Why the study?
Does infusion of nitroprusside or dobutamine improve haemodynamic and metabolic parameters compared to saline in an experimental model of myocardial infarction with left ventricular failure?
Does infusion of nitroprusside or dobutamine improve haemodynamic and metabolic parameters compared to saline in an experimental model of myocardial infarction with left ventricular failure?
In an experimental canine model of myocardial infarction with heart failure, the vasodilator nitroprusside reduced myocardial oxygen consumption while the inotrope dobutamine increased it, suggesting a metabolic advantage for vasodilators.
Answers are grounded in this paper and cite their sources.
Supports vasodilator preference for metabolic efficiency in experimental HF; leaves open clinical translation in humans.
Following coronary embolisation and onset of left ventricular failure 27 awake dogs were randomly assigned to infusion of saline (controls), nitroprusside, or dobutamine (a new inotropic agent). Nitroprusside and dobutamine both increased cardiac output and lowered left ventricular filling pressure while raising coronary sinus flow. Dobutamine, however, increased myocardial oxygen consumption whereas nitroprusside reduced it. Therefore vasidilators may be more beneficial than inotropic agents in acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Franciosa et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: